![U.S. FDA authorizes updated COVID booster for children aged 5-11](https://i-invdn-com.investing.com/news/pfizer_2_800x533_L_1412602205.jpg)
(Reuters) – The U.S. Food and Drug Administration on Wednesday authorized Omicron-tailored COVID-19 booster shots from Moderna (NASDAQ:) Inc as well as Pfizer Inc (NYSE:) and its partner BioNTech SE (NASDAQ:) for children, a move that will boost the government’s fall vaccination campaign.
Be the first to comment